Home: PCU
6|2003: Judd W Moul, MD, FACS: Select publications
Select publications
Publications discussed by Dr Moul
Bolla M et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial. Lancet 2002;360(9327):103-6. Abstract
D'Amico AV et al. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 2003;21(11):2163-72. Abstract
D'Amico AV et al. Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Natl Cancer Inst 2003;95(18):1376-83. Abstract
Pilepich MV et al. Phase III trial of androgen suppression adjuvant to definitive radiotherapy. Long term results of RTOG study 85-31. Proc ASCO 2003;Abstract 1530.
See W et al. Immediate treatment with bicalutamide 150 mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostate cancer. Eur Urol 2003;44(5):512-8. Abstract
See WA et al. Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: First analysis of the early prostate cancer program. J Urol 2002;168(2):429-35. Abstract
Thompson IM et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349(3):215-24. Abstract
Immediate versus delayed hormonal therapy
Crawford ED. Early versus late hormonal therapy: Debating the issues. Urology 2003;61(2 Suppl 1):8-13. Abstract
Mcleod DG. Emerging role of adjuvant hormonal therapy. Urology 2002 Sep;60(3 Suppl 1):13-20. Abstract
Messing E. The timing of hormone therapy for men with asymptomatic advanced prostate cancer. Urol Oncol 2003;21(4):245-54. Abstract
Messing EM et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 1999;341(24):1781-8. Abstract
Moul JW. Rising PSA after local therapy failure: Immediate vs deferred treatment. Oncology (Huntingt) 1999;13(7):985-90, 993. Abstract
Newling D. Advanced prostate cancer: Immediate or deferred hormone therapy? Eur Urol 2001;39 Suppl 1:15-21. Abstract
See W et al. Immediate treatment with bicalutamide 150mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostate cancer. Eur Urol 2003;44(5):512-7. Abstract
See WA et al. Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: First analysis of the early prostate cancer program. J Urol 2002;168(2):429-35. Abstract
Walsh PC et al. A structured debate: Immediate versus deferred androgen suppression in prostate cancer-evidence for deferred treatment. J Urol 2001;166(2):508-15. Abstract
|
